BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

516 related articles for article (PubMed ID: 11261079)

  • 1. From digoxin to angiotensin-converting enzyme inhibitors: issues in pharmacotherapy for congestive heart failure.
    Hackenbruck HA
    Clin Excell Nurse Pract; 2000 Jul; 4(4):197-204. PubMed ID: 11261079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Trends in pharmacological treatment of congestive heart failure].
    Halawa B
    Pol Merkur Lekarski; 1999 Mar; 6(33):152-6. PubMed ID: 10365602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacologic treatment of chronic congestive heart failure].
    Halawa B
    Przegl Lek; 1996; 53(3):119-23. PubMed ID: 8754362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Drug treatment of cardiac insufficiency with systolic dysfunction].
    Follath F
    Praxis (Bern 1994); 1997 Feb; 86(7):254-7. PubMed ID: 9139344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Drug therapy of cardiac insufficiency: status 1995].
    Rickenbacher P; Buser P; Osswald S; Pfisterer M
    Schweiz Med Wochenschr; 1996 May; 126(21):933-45. PubMed ID: 8693314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin-converting enzyme inhibitors in congestive heart failure.
    Deedwania PC
    Arch Intern Med; 1990 Sep; 150(9):1798-805. PubMed ID: 2132302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current concepts in clinical therapeutics: congestive heart failure.
    Klamerus KJ
    Clin Pharm; 1986 Jun; 5(6):481-98. PubMed ID: 2872992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on digoxin therapy in congestive heart failure.
    Haji SA; Movahed A
    Am Fam Physician; 2000 Jul; 62(2):409-16. PubMed ID: 10929703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic implications of treatment guidelines for congestive heart failure.
    Shibata MC; Nilsson C; Hervas-Malo M; Jacobs P; Tsuyuki RT
    Can J Cardiol; 2005 Dec; 21(14):1301-6. PubMed ID: 16341301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ACE inhibitors in congestive heart failure.
    Kantner TR
    J Fam Pract; 1992 Sep; 35(3):305-14. PubMed ID: 1517728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do evidence-based treatments provide incremental benefits to patients with congestive heart failure already receiving angiotensin-converting enzyme inhibitors? A secondary analysis of one-year outcomes from the Assessment of Treatment with Lisinopril and Survival (ATLAS) study.
    Majumdar SR; McAlister FA; Cree M; Chang WC; Packer M; Armstrong PW;
    Clin Ther; 2004 May; 26(5):694-703. PubMed ID: 15220013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does aspirin interfere with the therapeutic efficacy of angiotensin-converting enzyme inhibitors in hypertension or congestive heart failure?
    Nawarskas JJ; Spinler SA
    Pharmacotherapy; 1998; 18(5):1041-52. PubMed ID: 9758314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug therapy of chronic heart failure in the elderly: the current state of clinical-trial evidence.
    Dulin BR; Krum H
    Curr Opin Cardiol; 2006 Jul; 21(4):393-9. PubMed ID: 16755210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of pharmacologic treatment of congestive heart failure in elderly nursing home residents and related issues: a review of the literature.
    Litaker JR; Chou JY
    Clin Ther; 2003 Jul; 25(7):1918-35. PubMed ID: 12946542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. National patterns of angiotensin-converting enzyme inhibitor use in congestive heart failure.
    Stafford RS; Saglam D; Blumenthal D
    Arch Intern Med; 1997 Nov; 157(21):2460-4. PubMed ID: 9385297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Is digoxin effective in the treatment of heart insufficiency in patients with sinus rhythm?].
    Henriksen OM; Gadsbøll N
    Ugeskr Laeger; 1999 May; 161(22):3269-74. PubMed ID: 10485204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological treatment of congestive heart failure in Canada: a description of care in five provinces.
    Cox JL; Ramer SA; Lee DS; Humphries K; Pilote L; Svenson L; Tu JV;
    Can J Cardiol; 2005 Mar; 21(4):337-43. PubMed ID: 15838560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heart failure secondary to left ventricular systolic dysfunction. Therapeutic advances and treatment recommendations.
    Dracup K
    Nurse Pract; 1996 Sep; 21(9):56-8, 61, 65-8. PubMed ID: 8884795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Left ventricular diastolic heart failure with normal left ventricular systolic function in older persons.
    Aronow WS
    J Lab Clin Med; 2001 May; 137(5):316-23. PubMed ID: 11329528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of angiotensin-converting enzyme inhibitors and digoxin on health outcomes of very old patients with heart failure. SAGE Study Group. Systematic Assessment of Geriatric drug use via Epidemiology.
    Gambassi G; Lapane KL; Sgadari A; Carbonin P; Gatsonis C; Lipsitz LA; Mor V; Bernabei R
    Arch Intern Med; 2000 Jan; 160(1):53-60. PubMed ID: 10632305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.